• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Novartis Ag ADR (NY: NVS )

    107.08 +0.27 (+0.25%)
    Official Closing Price Updated: 7:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Novartis Ag ADR

    < Previous 1 2
    ...
    29 30 31 32 33 34 35 36 37
    ...
    42 43 Next >
    Novartis To Offload Its Stake Back To Roche For $20.7B
    Novartis AG (NYSE: NVS), a shareholder in Roche Holdings AG (OTC: RHHBY) for more than 20 years, would sell its entire stake, which is nearly one-third voting... 
    Via Benzinga
    Energize – A First-of-Its-Kind Program to Increase Access to Renewable Energy for Pharmaceutical Suppliers
    SOURCE: Novartis 
    Via 3BL Media
    Topics Emissions Supply Chain
    Exposures Supply Chain
    Novartis Inks $1.3B Protein Degradation Deal With UK's Dunad
    The U.K.-based Dunad Therapeutics has entered a strategic collaboration and license agreement with Novartis AG (NYSE: NVS) to generate orally... 
    Via Benzinga
    FDA Approves Novartis' Scemblix In Two Chronic Myeloid Leukemia Settings
    The FDA has approved Novartis AG's (NYSE: NVS) Scemblix (asciminib) for chronic myeloid leukemia (CML) in two distinct indications. The FDA granted... 
    Via Benzinga
    Exposures Product Safety
    How To Relieve Stress - New Book, Invisible Stress By Award-Winning Author Sylvia Lafair: Kindle Version to Be Available at No Charge November 3-5, 2021
    November 01, 2021 -- Sylvia Lafair is the founder of Creative Energy Options (CEOinc), a global business consulting firm and the world's leading authority in Pattern Breakthrough Leadership... 
    Via 24-7 Press Release
    Topics Lawsuit
    Exposures Financial Legal
    Earnings Scheduled For October 26, 2021
    Companies Reporting Before The Bell • Veoneer (NYSE:VNE) is likely to report quarterly loss at $0.83 per share on revenue of $408.69 million. • Aarons (NYSE:AAN)... 
    Via Benzinga
    Skin Cancer Therapeutics Market to Witness Massive Growth by 2028 : Bristol Myers Squibb, Eli Lilly, Roche
    Stay up-to-date with Skin Cancer Therapeutics Market research offered by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. 
    Via SBWire
    Exposures COVID-19
    Tuesday Market Coverage
    Thermo Electron fell on the publication of its social responsibility report today. 
    Via Talk Markets
    Novartis (NVS) Q3 2021 Earnings Call Transcript
    NVS earnings call for the period ending September 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Wazoku Continues Global Expansion After Strengthening Latin American Presence
    The addition of the Channge crowd plus in-market team meets the needs of Wazoku's global clients and adds greater diversity to the existing InnoCentive crowd 
    Via Newswire.com
    Topics Stocks
    Exposures US Equities
    Novartis Boosts Guidance For These Key Drugs After Their Bang-Up Quarter
    Novartis stock inched higher Tuesday after the company reported a mixed third quarter, but increased guidance for two drugs. 
    Via Investor's Business Daily
    Novartis: Q3 Earnings Insights
    Novartis (NYSE:NVS) reported its Q3 earnings results on Tuesday, October 26, 2021 at 08:00 AM. Here's what investors need to know about the announcement. Earnings... 
    Via Benzinga
    The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Anaptys Sells Royalties Due On Cancer Drug Jemperli To Sagard For $250M... 
    Via Benzinga
    Novartis Mulls Strategic Options For Sandoz, Reaffirms FY21 Outlook
    Novartis AG (NYSE: NVS) reported that its Q3 net income climbed 43% to $2.76 billion. EPS reached $1.23, up 45% Y/Y. Earnings: The Company posted a core EPS of $1.71,... 
    Via Benzinga
    Cyber Currency
    Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck. 
    Via Talk Markets
    A Preview Of Novartis's Earnings
    Novartis (NYSE:NVS) is set to give its latest quarterly earnings report on Tuesday, 2021-10-26. Here's what investors need to know before the announcement. Analysts estimate that... 
    Via Benzinga
    Price To Earnings Ratio Insights For Novartis
    In the current market session, Novartis Inc. (NYSE:NVS) is trading at $84.51, after a 0.19% decrease. However, over the past month, the stock increased by 1.91%, and... 
    Via Benzinga
    Global Pasireotide Market Market Overview and Forecast Report 2021:Novartis, ,
    QY Research has made a brilliant attempt to elaborately and meticulously analyze the global Pasireotide market in its latest report. All of the market forecasts presented in the report are authentic... 
    Via SBWire
    Topics Initial Public Offering
    Exposures Securities Market
    Global Pasireotide Drugs Market Industry Professional 2021:Novartis, ,
    QY Research has made a brilliant attempt to elaborately and meticulously analyze the global Pasireotide Drugs market in its latest report. All of the market forecasts presented in the report are... 
    Via SBWire
    Topics Initial Public Offering
    Exposures Securities Market
    Global Parkinsons Disease Drugs Market Market Development Overview 2021:Johnson & Johnson, Gilead Sciences, Pacira
    QY Research has made a brilliant attempt to elaborately and meticulously analyze the global Parkinsons Disease Drugs market in its latest report. All of the market forecasts presented in the report are... 
    Via SBWire
    Topics Initial Public Offering
    Exposures Securities Market
    Global Parkinson's Disease (PD) Drugs Market Industry Chain Research Report 2021:Boehringer Ingelheim, GlaxoSmithKline, Novartis
    QY Research has made a brilliant attempt to elaborately and meticulously analyze the global Parkinson's Disease (PD) Drugs market in its latest report. All of the market forecasts presented in the... 
    Via SBWire
    Topics Initial Public Offering
    Exposures Securities Market
    The Alliance for Regenerative Medicine Announces Election of 2022 Officers, Executive Committee, and Board of Directors
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Novartis Extends Fill/Finish Support For Pfizer/BioNTech COVID-19 Vaccines
    Novartis AG (NYSE: NVS) has agreed to expand its fill-and-finish support for Pfizer Inc (NYSE: PFE) / BioNTech SE (NASDAQ: BNTX) COVID-19... 
    Via Benzinga
    Exposures COVID-19
    Wednesday Market Coverage
    Today gold rose again despite the active market for bitcoin and the lower Chinese demand for mine products like iron and coal. 
    Via Talk Markets
    Gene Therapy Market Worth $13.0 Billion by 2024 - Exclusive Report by MarketsandMarkets(TM)
    Chicago, Illinois--(Newsfile Corp. - October 20, 2021) - According to the new market research report "Gene Therapy Market by Vectors... 
    Via Newsfile
    The MDS Foundation Celebrates MDS World Awareness Day With Their 4th Annual Move for MDS 5k Walk at Boston Common and Virtually Around the World
    Friendly Community Walks to Advance Awareness & Accelerate Research for Myelodysplastic Syndromes - a Rare Blood Cancer 
    Via Newswire.com
    The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio
    Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Entasis Announces Positive Data For Late-Stage Study Of SUL-DUR In... 
    Via Benzinga
    Great Place to Work® Announces the World’s Best Workplaces™ 2021
    Great Place to Work® Announces the World’s Best Workplaces™ 2021 
    Via News Direct
    Acute Myeloid Leukemia (AML) Therapeutics market:Which Trend Will Emerge in Near Future? with Top Companies Like: Bristol-Myers Squibb, Novartis, Roche
    This report is a compilation of a number of extensive, authentic research studies on the global Acute Myeloid Leukemia (AML) Therapeutics market that help the reader to gain profound knowledge of each... 
    Via SBWire
    Topics Initial Public Offering
    Exposures Securities Market
    Pharma & Cosmetics Market to See Major Growth by 2026 : Roche, Novartis, Pfizer
    2020-2029 Report on Global Pharma & Cosmetics Market by Player, Region, Type, Application and Sales Channel is latest research study released by HTF MI evaluating the market risk side analysis,... 
    Via SBWire
    < Previous 1 2
    ...
    29 30 31 32 33 34 35 36 37
    ...
    42 43 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.